Novel peptide hormones with calcitonin-like activity
US4663309A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 27, 1985 |
| Grant date | May 5, 1987 |
| Priority date | — |
| Expiry date | Feb 27, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula: ##STR1## wherein R.sub.1 is a moiety selected from the group consisting of ##STR2## R.sub.2 -R.sub.22 are amino acid moieties wherein R.sub.2 is an optional moiety which when present is selected from the group consisting of Ser and Gly, PA1 R.sub.8 is Leu or Val, PA1 R.sub.10 is Gln, Lys, or Gly, PA1 R.sub.11, R.sub.14, and R.sub.20 are each independently selected from the group consisting of Gln and Lys, PA1 R.sub.12 is Leu or Trp, PA1 R.sub.13 is Gln or Ser, PA1 R.sub.17 is Gln or His, PA1 R.sub.19 is Leu or Cys, PA1 R.sub.21 is Gln or Thr, PA1 R.sub.22 is an optional moiety which when present is selected from the group consisting of Leu and Tyr; PA0 R.sub.24 -R.sub.31 comprise a series of eight amino acids each independently selected from the group consisting of Gly, Ser, Thr, Cys, Tyr, Asn, Gln, Asp, Glu, Lys, Arg, and His, with the proviso that not more than one of said eight amino acids may be selected from the group consisting of Asp, Glu, Lys, Arg, and His, and with the proviso that no four or more of said eight amino acids will spontaneously form helical, .beta.-sheet, or .beta.-turn conformations; with the further proviso that when R.sub.19 is Cy…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.